Answers are grounded in this paper and cite their sources.
This is a protocol for a Cochrane Review (Overview). The objectives are as follows: To provide an overview of the therapeutic efficacy of pharmacological therapies for fibromyalgia, and to report on adverse events associated with their use. The major comparison of interest will be with placebo.
No takes yet. Share an insight, caveat, or question.
Häuser et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: